1. Home
  2. ULH vs CCCC Comparison

ULH vs CCCC Comparison

Compare ULH & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Logistics Holdings Inc.

ULH

Universal Logistics Holdings Inc.

HOLD

Current Price

$15.79

Market Cap

354.9M

Sector

Industrials

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.93

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULH
CCCC
Founded
1932
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
354.9M
404.7M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
ULH
CCCC
Price
$15.79
$3.93
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$20.00
$12.20
AVG Volume (30 Days)
52.0K
2.2M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
$1,461,708,000.00
$35,947,000.00
Revenue This Year
$2.73
N/A
Revenue Next Year
$5.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$11.73
$1.36
52 Week High
$30.76
$4.60

Technical Indicators

Market Signals
Indicator
ULH
CCCC
Relative Strength Index (RSI) 43.70 56.34
Support Level $14.82 $2.10
Resistance Level $18.76 $4.60
Average True Range (ATR) 1.05 0.41
MACD 0.07 -0.04
Stochastic Oscillator 12.74 41.02

Price Performance

Historical Comparison
ULH
CCCC

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada, and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The firm has three reportable segments, namely contract logistics, intermodal, and trucking. The company generates the key revenue from Contract Logistics, which provides value-added and dedicated transportation services to support inbound and internal logistics requirements of industrial manufacturers and retailers, generally under contractual arrangements of one year or longer. Geographically, the firm generates the majority of its revenue from the United States, followed by Mexico, Canada, and Colombia.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: